Ann: Half Yearly Report, page-100

Hi all

To me the general direction of the company's efforts have not changed and the dollars, agree or not, are pretty much as expected .... expensive sales efforts to get the sales of CC up
BUT
that would not explain a back-room drama which sees the BOD clear-out we just witnessed ... but we don't really know why.
SO
Looking forward it must be the strategy we are going forward with in regards to the HSV2 VAX ... for example, when the news breaks in the next few weeks, what then? We don't have anywhere near the money required for a big Phase 3 trial.
So what to do? .... maybe this is where the philosophical differences lie between to old BOD and the new?
This new innovation fund doesn't hand out grants of cash, it is essentially like a placement .. more dilution for you and me ....I can understand that Twiggy and Prof are likely to want to be smiled upon by the politicians and thus likely to be happy to take the Govt placement (at what price?)
BUT
maybe the BOD fellows who have just departed were actually the good guys who didn't want any more dilution....
Any thoughts?